109 related articles for article (PubMed ID: 23991992)
21. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
22. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
23. [Influence of Serum TGF-β1 and EGFR Levels on the Therapeutic Effect of High-Dose AraC in Patients with Acute Myeloid Leukemia Based on the Decision Curve].
Zhang JZ; Liu M; Huang ZP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):407-412. PubMed ID: 35395971
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
25. Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study.
Kamal AM; El-Hefny NH; Hegab HM; El-Mesallamy HO
Hematology; 2016 Dec; 21(10):567-575. PubMed ID: 27158980
[TBL] [Abstract][Full Text] [Related]
26. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
[TBL] [Abstract][Full Text] [Related]
27. Altered serum levels of elements in acute leukemia cases in Turkey.
Demir C; Demir H; Esen R; Sehitogullari A; Atmaca M; Alay M
Asian Pac J Cancer Prev; 2011; 12(12):3471-4. PubMed ID: 22471499
[TBL] [Abstract][Full Text] [Related]
28. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer--evaluation of the prognostic significance of these agents.
Sulkowski S; Wincewicz A; Zalewski B; Famulski W; Lotowska JM; Koda M; Sobaniec-Lotowska ME; Mysliwiec M; Baltaziak M; Pawlak K; Sulkowska M
Clin Chem Lab Med; 2009; 47(11):1439-45. PubMed ID: 19817649
[TBL] [Abstract][Full Text] [Related]
30. Crosstalk between EGFR and p53 in hepatocellular carcinoma.
Cioca A; Cimpean A; Ceausu R; Fit AM; Zaharie T; Al-Hajjar N; Puia V; Raica M
Asian Pac J Cancer Prev; 2014; 15(19):8069-73. PubMed ID: 25338986
[TBL] [Abstract][Full Text] [Related]
31. [Abnormal expression of hematopoietic regulatory factors in newly diagnosed patients with acute myeloid leukemia].
Xiao R; Chen T; Zhou M; Yang JH; Jiang NK; Zhang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1124-7. PubMed ID: 21129244
[TBL] [Abstract][Full Text] [Related]
32. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
33. Tumor markers in leukemia: evaluation of serum levels of different forms of sialic acid, Regan isoenzyme and lactate dehydrogenase.
Patel PS; Adhvaryu SG; Baxi BR
Int J Biol Markers; 1991; 6(3):177-82. PubMed ID: 1791311
[TBL] [Abstract][Full Text] [Related]
34. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
35. Clinical correlation of circulating heat shock protein 70 in acute leukemia.
Yeh CH; Tseng R; Hannah A; Estrov Z; Estey E; Kantarjian H; Albitar M
Leuk Res; 2010 May; 34(5):605-9. PubMed ID: 19800118
[TBL] [Abstract][Full Text] [Related]
36. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
37. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia.
Balss J; Thiede C; Bochtler T; Okun JG; Saadati M; Benner A; Pusch S; Ehninger G; Schaich M; Ho AD; von Deimling A; Krämer A; Heilig CE
Leukemia; 2016 Apr; 30(4):782-8. PubMed ID: 26582645
[TBL] [Abstract][Full Text] [Related]
39. [Observation of D-dimer levels in serum of patients with acute leukemia].
Cielińska S; Urbaniak-Kujda D; Kiełbiński M; Milczarska J; Kuliczkowski K
Pol Arch Med Wewn; 2000; 103(1-2):7-14. PubMed ID: 11236262
[TBL] [Abstract][Full Text] [Related]
40. Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
Anagnostopoulou E; Papanastasopoulou C; Papastamataki M; Kotsiou A; Topouzoglou Z; Anagnostopoulos N; Sitaras N
Acta Haematol; 2017; 138(1):44-51. PubMed ID: 28719902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
